MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Mast Therapeutics Company Profile (NASDAQ:MSTX)

Consensus Ratings for Mast Therapeutics (NASDAQ:MSTX) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (541.57% upside)

Analysts' Ratings History for Mast Therapeutics (NASDAQ:MSTX)
Show:
DateFirmActionRatingPrice TargetActions
5/28/2015Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2013 forward)